3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1/2
2
Phase EARLY_PHASE1
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Plasma cell
1
Myeloid
1
Lymphoid
1
Conditions
Breast Neoplasms
71
Carcinoma, Non-Small-Cell Lung
69
Multiple Myeloma
55
Prostatic Neoplasms
54
Colorectal Neoplasms
42
Leukemia, Myeloid, Acute
39
Neoplasms
38
Melanoma
34
Lymphoma
33
Ovarian Neoplasms
30
Lymphoma, Non-Hodgkin
29
Lung Neoplasms
28
Squamous Cell Carcinoma of Head and Neck
27
Sarcoma
27
Neoplasm Metastasis
25
Carcinoma, Hepatocellular
24
Pancreatic Neoplasms
23
Endometrial Neoplasms
23
Glioma
22
Carcinoma, Renal Cell
22
Lymphoma, Large B-Cell, Diffuse
21
Hodgkin Disease
21
Recurrence
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Head and Neck Neoplasms
20
Urinary Bladder Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
18
Esophageal Neoplasms
17
Hematologic Neoplasms
16
Interventions
asciminib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Leukemia, Myeloid
×
30 days
×
Clear all
NCT05143840
2026-06-02
ALERTCML
University of Alabama at Birmingham
Phase 2
Recruiting
100 enrolled
NCT07292272
2026-05-18
HALTAging-1
University of Nebraska
Phase 2
Recruiting
180 enrolled